Operator: Hello, and welcome to 23andMe s Fiscal Year 2023 Fourth Quarter and Full Year Financial Results Conference Call. As a reminder, this call is being recorded.
/PRNewswire/ DelveInsight s Sickle Cell Disease Market Insights report includes a comprehensive understanding of current treatment practices, sickle cell.